Literature DB >> 17177825

Modulation of alpha-smooth muscle actin expression in fibroblasts by transforming growth factor-beta isoforms: an in vivo and in vitro study.

G Serini1, G Gabbiana.   

Abstract

Myofibroblasts are granulation tissue fibroblasts bearing ultrastructural and biochemical features of smooth muscle cells, such as cytoplasmic microfilaments and alpha-smooth muscle actin expression. They appear transiently during wound healing and more permanently during several pathologic situations such as fibrotic diseases. Transforming growth factor-beta1 has been suggested to be an important promoter of the myofibroblastic phenotype. Here we show that (1) transforming growth factor-beta2, like transforming growth factor-beta1, induces myofibroblast formation in vivo and in vitro; (2) transforming growth factor-beta3 acts as a negative regulator of the myofibroblastic phenotype in vivo but not in vitro; and (3) in vitro, the three different transforming growth factor-beta isoforms are equally able to induce alpha-smooth muscle actin messenger RNA and protein expression in growing and quiescent cultured human and rat subcutaneous tissue fibroblasts. These data confirm that in vitro the behavior of the three different transforming growth factor-beta isoforms is similar, whereas in vivo transforming growth factor-beta isoforms possibly play different but complementary roles in myofibroblast modulation during wound repair.

Entities:  

Year:  1996        PMID: 17177825     DOI: 10.1046/j.1524-475X.1996.40217.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  17 in total

1.  Microvascular mural cell functionality of human embryonic stem cell-derived mesenchymal cells.

Authors:  Nolan L Boyd; Sara S Nunes; Jenny D Jokinen; Laxminarayanan Krishnan; Yinlu Chen; Kristyn H Smith; Steven L Stice; James B Hoying
Journal:  Tissue Eng Part A       Date:  2011-03-04       Impact factor: 3.845

2.  Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs.

Authors:  G Xu; M Redard; G Gabbiani; P Neuville
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

Review 3.  The myofibroblast matrix: implications for tissue repair and fibrosis.

Authors:  Franco Klingberg; Boris Hinz; Eric S White
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

4.  Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation.

Authors:  Bimal Vyas; Keiko Ishikawa; Suzy Duflo; Xia Chen; Susan L Thibeault
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-05       Impact factor: 1.547

5.  Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression.

Authors:  Kathleen C Flanders; Lalage M Wakefield
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-25       Impact factor: 2.673

6.  Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling.

Authors:  Josefine Stockert; Till Adhikary; Kerstin Kaddatz; Florian Finkernagel; Wolfgang Meissner; Sabine Müller-Brüsselbach; Rolf Müller
Journal:  Nucleic Acids Res       Date:  2010-09-15       Impact factor: 16.971

7.  Heart regeneration in the salamander relies on macrophage-mediated control of fibroblast activation and the extracellular landscape.

Authors:  J W Godwin; R Debuque; E Salimova; N A Rosenthal
Journal:  NPJ Regen Med       Date:  2017-07-27

8.  The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1.

Authors:  G Serini; M L Bochaton-Piallat; P Ropraz; A Geinoz; L Borsi; L Zardi; G Gabbiani
Journal:  J Cell Biol       Date:  1998-08-10       Impact factor: 10.539

9.  TGF-β3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats.

Authors:  Zhen Chang; Yo Kishimoto; Ayesha Hasan; Nathan V Welham
Journal:  Dis Model Mech       Date:  2013-10-02       Impact factor: 5.758

10.  TGF-β1 and TGF-β2 abundance in liver diseases of mice and men.

Authors:  Anne Dropmann; Tatjana Dediulia; Katja Breitkopf-Heinlein; Hanna Korhonen; Michel Janicot; Susanne N Weber; Maria Thomas; Albrecht Piiper; Esther Bertran; Isabel Fabregat; Kerstin Abshagen; Jochen Hess; Peter Angel; Cédric Coulouarn; Steven Dooley; Nadja M Meindl-Beinker
Journal:  Oncotarget       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.